TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -8 | -4 | -16 | -36 | -51 | -53 | -28 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/06 13:26 | 3/3/06 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Riggs Randall B | AL | O | SVP Busi | S | -31 | 20.38 | 21 | -2 | -100 | 0 | -8 | -4 | -16 | -36 | -51 | -53 | |||||||||
2/25/04 16:13 | 2/23/04 | LEXG | Lexicon Genetics Inc/tx | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Randall B | TX | O | SVP,Corp | S.d | -244 | 6.51 | 0 | -38 | -71 | 15 | D | ||||||||||||||
1/8/04 17:21 | 1/6/04 | LEXG | Lexicon Genetics Inc/tx | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Randall B | TX | O | SVP,Corp | S.d | -161 | 6.43 | 0 | -25 | -63 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |